Jan 03, 2018 13:31 pm UTC| Business
SAN DIEGO, Jan. 03, 2018 -- Global Payout, Inc. (OTCPink:GOHE) ("Global") is pleased to announce that its majority owned subsidiary, MoneyTrac Technology, Inc. ("MTRAC" "MoneyTrac", the "Company") has promoted Ms....
DIGATRADE Executes Development Contract for Mobile App iOS & Android
Jan 03, 2018 13:31 pm UTC| Business
VANCOUVER, British Columbia, Jan. 03, 2018 -- via OTC PR WIRE -- DIGATRADE FINANCIAL CORP (OTCQB:DIGAF) a digital-asset (Bitcoin) exchange and blockchain development services company today announced the execution of a...
Espero BioPharma to Present at Biotech Showcase on January 9, 2018
Jan 03, 2018 13:31 pm UTC| Business
JACKSONVILLE, Fla. and IRVINE, Calif., Jan. 03, 2018 -- Espero BioPharma, a biopharmaceutical company focusing on the late-stage development and commercialization of drugs to treat cardiovascular diseases, today...
Jan 03, 2018 13:31 pm UTC| Business
Company offers outcomes-based rebates and an innovative contracting model that support patient access in the U.S. while aiming to reduce risk and financial burden for payers and treatment centers Harvard Pilgrim and...
HD Supply Enters into Definitive Agreement to Acquire A.H. Harris
Jan 03, 2018 13:31 pm UTC| Business
ATLANTA, Jan. 03, 2018 -- HD Supply Holdings, Inc. (Nasdaq:HDS), one of the largest industrial distributors in North America, today announced that it has entered into a definitive agreement to purchase A.H. Harris...
Vitality Biopharma Introduces Cannabinoid Pharmaceutical VITA-100 as Prodrug of THC
Jan 03, 2018 13:31 pm UTC| Business
LOS ANGELES, Jan. 03, 2018 -- Vitality Biopharma, Inc. (OTCQB:VBIO) (“Vitality” or the “Company”) a corporation dedicated to the development of cannabinoid prodrug pharmaceuticals, and to unlocking the power of...
Jan 03, 2018 13:31 pm UTC| Business
FREMONT, Calif., Jan. 03, 2018 -- Zosano Pharma Corp. (NASDAQ:ZSAN) (“Zosano” or the “Company”) a clinical stage biopharmaceutical company focused on providing rapid systemic administration of therapeutics to subjects...